Population
Failing human myocardium and nonfailing controls
Design
Preclinical
Authors
Loading...
Alpha G40 merits study as a contributor to beta-adrenergic hyporesponsiveness in heart failure; leaves open its value as a therapeutic target.
Increased alpha G40 activity is a marker for failing myocardium and may explain the diminished responsiveness to beta-adrenergic agonists in heart failure.
Feldman et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: